(Total Views: 117)
Posted On: 02/14/2023 10:45:49 AM
Post# of 145202

$CGEN News Article - Rilvegostomig, AstraZeneca's Bi-specific Antibody Derived from Compugen's COM902, Expected to Progress into Phase 3 https://marketwirenews.com/news-releases/rilv...98129.html


My Twitter: WhyteStocks